Clinical trial
Depakote-ER for Depressive and Bipolar Depression
NCT00226343 · Cambridge Health Alliance, Other · Completed
Key facts
| NCT number | NCT00226343 |
|---|---|
| Title | Depakote-ER for Depressive and Bipolar Depression |
| Official title | Phase 4 Study: Double-blind Placebo-controlled Trial of Depakote-ER for Depressive and Anxiety Symptoms in Non-refractory Bipolar Depression |
| Lead sponsor | Cambridge Health Alliance, Other |
| Collaborators | Northwestern University |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Depakote-ER |
| Enrollment | 25 |
| Start date | Aug 1, 2003 |
| Primary completion | Jan 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Sep 27, 2005 |
| Last update posted | Apr 18, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: